
JP Morgan’s latest rating for EDIT stock
In a filing, Editas Medicine Inc revealed its EVP, CHIEF FINANCIAL OFFICER Lucera Erick unloaded Company’s shares for reported $7030.0
In a filing, Editas Medicine Inc revealed its EVP, CHIEF FINANCIAL OFFICER Lucera Erick unloaded Company’s shares for reported $7030.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Editas Medicine Inc revealed its EVP, CHIEF FINANCIAL OFFICER Lucera Erick unloaded Company’s shares for reported $7030.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Editas Medicine
Editas Medicine Inc’s recent filing unveils that its EVP, CHIEF FINANCIAL OFFICER Lucera Erick unloaded Company’s shares for reported $7030.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Editas Medicine Inc’s recently made public that its EVP, CHIEF FINANCIAL OFFICER Lucera Erick unloaded Company’s shares for reported $7030.0
In a filing, Editas Medicine Inc revealed its Officer O’Neill Gilmore Neil acquired Company’s shares for reported $65100.0 on Mar
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.